Ultragenyx Pharmaceutical (RARE) Shareholder's Equity (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) Shareholder's Equity (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.77 Bn | 2.36 Bn | 106.00 Mn | -236.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -236.00 Mn |
| Dec 31, 2025 | -80.00 Mn |
| Sep 30, 2025 | 9.16 Mn |
| Jun 30, 2025 | 151.29 Mn |
| Mar 31, 2025 | 144.00 Mn |
| Dec 31, 2024 | 255.00 Mn |
| Sep 30, 2024 | 346.83 Mn |
| Jun 30, 2024 | 432.42 Mn |
| Mar 31, 2024 | 140.26 Mn |
| Dec 31, 2023 | 275.00 Mn |
| Sep 30, 2023 | 31.71 Mn |
| Jun 30, 2023 | 129.03 Mn |
| Mar 31, 2023 | 220.48 Mn |
| Dec 31, 2022 | 352.00 Mn |
| Sep 30, 2022 | 468.83 Mn |
| Jun 30, 2022 | 678.07 Mn |
| Mar 31, 2022 | 796.42 Mn |
| Dec 31, 2021 | 922.56 Mn |
| Sep 30, 2021 | 933.67 Mn |
| Jun 30, 2021 | 972.17 Mn |